Skip to main content

STERIS plc company profile

  • STE · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$264.32+4.29%Close 13 Nov 2026

About STERIS plc

STERIS provides products and services that support patient care, with an emphasis on infection prevention. Its Healthcare segment sells consumables, endoscopy accessories, capital equipment such as sterilizers and surgical tables, and services including equipment maintenance, instrument repair and outsourced reprocessing to healthcare providers, mainly for sterile processing departments and procedural areas. Its Applied Sterilization Technologies segment offers contract sterilization and laboratory testing, along with sterilization equipment and control systems, for medical device and pharmaceutical manufacturers. Its Life Sciences segment supplies detergents, disinfectants, sterilizers, water and steam generators, and maintenance services to biopharmaceutical and medical device manufacturers. The company sells to Customers in many countries and operates in the Americas, Europe and Asia.

A summary of the business section of the company's latest annual report, filed 29 May 2026.

Company facts

TickerSTE · NYSE
SectorMedical devices
IndustryHealth Care Equipment
IndexS&P 500
Fiscal year ends31 March
Reporting currencyUSD
CIK1757898
Latest annual report10-K, filed 29 May 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Daniel A. CarestioPresident and CEO · Director354KSale under a 10b5-1 plan, 5 Jun 2026
Michael J. TokichSr. Vice Pres., CFO180KShares withheld for tax, 4 Jun 2025
J. Adam ZangerleSr. VP, Gen Counsel, and Sec.157KSale under a 10b5-1 plan, 15 Jun 2026
Richard C. BreedenDirector91.5KOption exercise, 2 Jun 2026
Cary L. MajorsSVP and President, Healthcare59.9KShares withheld for tax, 2 Jun 2026
Dr. Mohsen M. SohiDirector56.5KOption exercise, 10 Nov 2026
Mary Clare FraserSVP & Chief HRO42.4KShares withheld for tax, 4 Jun 2026
Karen L. BurtonSr. Vice Pres., CFO30.8KOption exercise, 11 Nov 2026
Cynthia L. FeldmannDirector20.7KOpen-market sale, 5 Mar 2026
Tamaro RenatoV.P. & Corporate Treasurer—Shares withheld for tax, 4 Jun 2026
Madsen JuliaSr. VP and GM, Life Sciences—Shares withheld for tax, 4 Jun 2026
Kohler Kenneth ESVP & GM, AST—Shares withheld for tax, 4 Jun 2026
McGowan LindseyVP, Chf. Comp. & Quality Offc.—Shares withheld for tax, 2 Jun 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

STE in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.